Genevant Sciences
Mahsa Alizadeh, Ph.D., is a highly experienced professional in the field of pharmaceutical development and manufacturing. Currently serving as Manager of LNP Manufacturing and previously as Scientist at Genevant Sciences since July 2021, Mahsa has a strong background in research and development acquired through roles as Postdoctoral Research Fellow at adMare BioInnovations and Graduate Research Assistant at the Centre for Blood Research at the University of British Columbia. Mahsa earned a Doctor of Philosophy in Polymer Chemistry from the University of British Columbia, following a Master of Science in Organic Chemistry and a Bachelor of Science in Applied Chemistry from the University of Tehran. Additionally, Mahsa has practical experience as an Analytical Chemist at Darou Pakhsh.
Genevant Sciences
Genevant is a technology-focused nucleic acid delivery company with world-class platforms, the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate and decades of expertise in nucleic acid drug development. They leverage world-class delivery systems and related technologies to bring new medicines to patients who need them. Genevant does this by selectively collaborating with leading pharma and biotech companies and fostering a culture of innovation that allows them to maintain our leadership position in the space.